Pancreatic Cancer Research

ResearcherKorea UniversityActive in the last 2 years

Hong Sik Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9726-5416; OpenAlex author ID A5028841219. Sources: ClinicalTrials.gov.

Their work

Papers
5 (first author 3, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper, 1 trial · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers

Papers 5

  1. Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin leve… Co-author DOI 10.1038/s41416-023-02474-w↗
  2. Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum … Co-author DOI 10.1038/s41416-023-02520-7↗
  3. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. First author DOI 10.4251/wjgo.v8.i7.555↗
  4. Rare case of pancreatic cancer with leptomeningeal carcinomatosis. First author DOI 10.3748/wjg.v21.i3.1020↗
  5. Expression of heat shock protein 70 modulates the chemoresponsiveness of pancreatic cancer. First author DOI 10.5009/gnl.2013.7.6.739↗

Trials 1

  1. A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients Principal investigator NCT02854072↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eun Kwang Choi · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
  2. Seung Ok Lee · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
  3. Young Woo Choi · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
  4. Ho Gak Kim · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
  5. Ho Soon Choi · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
  6. Yong‐Tae Kim · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
  7. Chang‐Hwan Park · 2 shared papers, 2024 · strength 0.33
  8. Jae Woo Kim · 2 shared papers, 2024 · strength 0.33
  9. Eui Joo Kim · 2 shared papers, 2024 · strength 0.33
  10. Mi‐Suk Park · 2 shared papers, 2024 · strength 0.33
  11. Y. Choi · 2 shared papers, 2024 · strength 0.33
  12. Si Young Song · 2 shared papers, 2024 · strength 0.33
  13. Jung Hyun Jo · 2 shared papers, 2024 · strength 0.33
  14. Hyungsik Roger Moon · 2 shared papers, 2024 · strength 0.33
  15. Dong Uk Kim · 2 shared papers, 2024 · strength 0.33
  16. Woo Jin Lee · 2 shared papers, 2024 · strength 0.33
  17. Kwang Hyuck Lee · 1 shared paper, 1 shared trial, 2015–2024 · strength 0.23
  18. Kwang Hyuck Lee · 1 shared paper, 2024 · strength 0.16
  19. Jong Jin Hyun · 3 shared papers, 2013–2016 · strength 0.14
  20. Yoon Tae Jeen · 3 shared papers, 2013–2016 · strength 0.14
  21. Hoon Jai Chun · 3 shared papers, 2013–2016 · strength 0.14
  22. Jae Min Lee · 2 shared papers, 2015–2016 · strength 0.10
  23. Chang Duck Kim · 2 shared papers, 2013–2016 · strength 0.09
  24. Woo Jin Lee · 1 shared trial, 2015 · strength 0.06
  25. Gwang Ha Kim · 1 shared trial, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.